| Isolation and structure of a brain constituent that binds to the cannabinoid receptor WA Devane, L Hanuš, A Breuer, RG Pertwee, LA Stevenson, G Griffin, ... Science 258 (5090), 1946-1949, 1992 | 7300 | 1992 |
| Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, NE Kaminski, ... Biochemical pharmacology 50 (1), 83-90, 1995 | 3823 | 1995 |
| Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide T Bisogno, L Hanuš, L De Petrocellis, S Tchilibon, DE Ponde, I Brandi, ... British journal of pharmacology 134 (4), 845-852, 2001 | 1397 | 2001 |
| 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor L Hanuš, S Abu-Lafi, E Fride, A Breuer, Z Vogel, DE Shalev, I Kustanovich, ... Proceedings of the National Academy of Sciences 98 (7), 3662-3665, 2001 | 1074 | 2001 |
| An endogenous cannabinoid (2-AG) is neuroprotective after brain injury D Panikashvili, C Simeonidou, S Ben-Shabat, L Hanuš, A Breuer, ... Nature 413 (6855), 527-531, 2001 | 933 | 2001 |
| Phytocannabinoids: a unified critical inventory LO Hanuš, SM Meyer, E Muńoz, O Taglialatela-Scafati, G Appendino Natural product reports 33 (12), 1357-1392, 2016 | 878 | 2016 |
| HU-308: A specific agonist for CB2, a peripheral cannabinoid receptor L Hanuš, A Breuer, S Tchilibon, S Shiloah, D Goldenberg, M Horowitz, ... Proceedings of the National Academy of Sciences 96 (25), 14228-14233, 1999 | 763 | 1999 |
| Cannabidiol–recent advances R Mechoulam, M Peters, E Murillo‐Rodriguez, LO Hanuš Chemistry & biodiversity 4 (8), 1678-1692, 2007 | 699 | 2007 |
| Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor L Hanus, A Gopher, S Almog, R Mechoulam Journal of medicinal chemistry 36 (20), 3032-3034, 1993 | 462 | 1993 |
| Early phytocannabinoid chemistry to endocannabinoids and beyond R Mechoulam, LO Hanuš, R Pertwee, AC Howlett Nature Reviews Neuroscience 15 (11), 757-764, 2014 | 429 | 2014 |
| A historical overview of chemical research on cannabinoids R Mechoulam, L Hanuš Chemistry and physics of lipids 108 (1-2), 1-13, 2000 | 379 | 2000 |
| Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects R Mechoulam, L Hanuš Chemistry and physics of lipids 121 (1-2), 35-43, 2002 | 369 | 2002 |
| Myrrh-commiphora chemistry LO Hanuš, T Řezanka, VM Dembitsky, A Moussaieff Biomedical papers 149 (1), 3-28, 2005 | 351 | 2005 |
| Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor T Sheskin, L Hanuš, J Slager, Z Vogel, R Mechoulam Journal of medicinal chemistry 40 (5), 659-667, 1997 | 344 | 1997 |
| Human metabolites of cannabidiol: a review on their formation, biological activity, and relevance in therapy I Ujváry, L Hanuš Cannabis and cannabinoid research 1 (1), 90-101, 2016 | 330 | 2016 |
| Cannabinoids and cytochrome P450 interactions O Zendulka, G Dovrtelova, K Nosková, M Turjap, A Sulcova, L Hanus, ... Current drug metabolism 17 (3), 206-226, 2016 | 289 | 2016 |
| Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase MH Rhee, Z Vogel, J Barg, M Bayewitch, R Levy, L Hanuš, A Breuer, ... Journal of medicinal chemistry 40 (20), 3228-3233, 1997 | 283 | 1997 |
| Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol R Gallily, Z Yekhtin, LO Hanuš Pharmacology & Pharmacy 6 (2), 75-85, 2015 | 196 | 2015 |
| Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids LO Hanuš Medicinal research reviews 29 (2), 213-271, 2009 | 180 | 2009 |
| Search for endogenous ligands of the cannabinoid receptor R Mechoulam, L Hanuš, BR Martin Biochemical pharmacology 48 (8), 1537-1544, 1994 | 170 | 1994 |
Raphael MechoulamProfessor of Medicinal Chemistry, Hebrew UniversityVerified email at cc.huji.ac.il
